Breaking News

TFF Pharmaceuticals Expands R&D Operations with New Austin Facility

Increases manufacturing capabilities to further expand thin film freezing applications.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

TFF Pharmaceuticals, a clinical-stage biopharma focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, is expanding its R&D operations through the lease of a new research and development facility in Austin, TX. The new facility of over 3,500 square feet increases TFF’s total lab space, adding a dedicated lab for downstream processing of products created via Thin Film Freezing, which will complement the company...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters